journal article·2008-11

Synthesis of novel biodegradable and self-assembling methoxy poly(ethylene glycol)–palmitate nanocarrier for curcumin delivery to cancer cells

Abhishek Sahu, Utpal Bora, Naresh Kasoju, Pranab Goswami

Acta Biomaterialia· Volume 4· Issue 6
Publisher page

Abstract

A novel polymeric amphiphile, mPEG-PA, was synthesized with methoxy poly(ethylene glycol) (mPEG) as the hydrophilic and palmitic acid (PA) as the hydrophobic segment. The conjugate prepared in a single-step reaction showed minimal toxicity on HeLa cells. (1)H nuclear magnetic resonance imaging and Fourier transform infrared spectroscopy revealed that the conjugation was through an ester linkage, which is biodegradable. Enzymes having esterase activity, such as lipase, can degrade the conjugate easily, as observed by in vitro studies. mPEG-PA conjugate undergoes self-assembly in an aqueous environment, as evidenced by fluorescence spectroscopic studies with pyrene as a probe. The mPEG-PA conjugate formed micelles in the aqueous solution with critical micelle concentration of 0.12 g l(-1). Atomic force microscopy and dynamic light scattering studies showed that the micelles were spherical in shape, with a mean diameter of 41.43 nm. The utility of mPEG-PA to entrap the potent chemopreventive agent curcumin in the core of nanocarrier was investigated. The encapsulation of a highly hydrophobic compound like curcumin in the nanocarrier makes the drug readily soluble in an aqueous system, which can increase the ease of dosing and makes intravenous dosing possible. Drug-loaded micelle nanoparticles showed good stability in physiological condition (pH 7.4), in simulated gastric fluid (pH 1.2) and in simulated intestinal fluid (pH 6.8). This micellar formulation can be used as an enzyme-triggered drug release carrier, as suggested by in vitro enzyme-catalyzed drug release using pure lipase and HeLa cell lysate. The IC(50) of free curcumin and encapsulated curcumin was found to be 14.32 and 15.58 microM, respectively.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Curcumin's Biomedical Applications · Dendrimers and Hyperbranched Polymers

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (36)

Show source-provided references
1. Multiple biological activities of curcumin: a short review10.1016/j.lfs.2005.12.007 ↗
2. Activation of transcription factor NF-κB is suppressed by curcumin (diferulolylmethane)10.1074/jbc.270.42.24995 ↗
3. Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages10.1006/phrs.1998.0404 ↗
4. Anticancer potential of curcumin: preclinical and clinical studies
5. Curcumin: the story so far10.1016/j.ejca.2005.05.009 ↗
6. Bioavailability of curcumin: problems and promises10.1021/mp700113r ↗
7. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers10.1055/s-2006-957450 ↗
8. Liposomal curcumin with and without oxaliplatin: effects on cell growth, apoptosis and angiogenesis in colorectal cancer10.1158/1535-7163.MCT-06-0556 ↗
9. Transport of liposomal and albumin loaded curcumin to living cells: an absorption and fluorescence spectroscopic study10.1016/j.bbagen.2006.06.012 ↗
10. Polymeric nanoparticle-encapsulated curcumin (“nanocurcumin”): a novel strategy for human cancer therapy10.1186/1477-3155-5-3 ↗
11. Loading of curcumin into macrophages using lipid-based nanoparticles10.1016/j.ijpharm.2007.10.033 ↗
12. Biodegradable microspheres of curcumin for treatment of inflammation
13. New cyclodextrin bioconjugates for active tumor targeting10.1080/10611860701349752 ↗
14. Enzyme catalysis: tool to make and break amygdalin hydrogelators from renewable resources: a delivery model for hydrophobic drugs10.1021/ja062650u ↗
15. High-performance liquid chromatography analysis of curcumin in rat plasma: application to pharmacokinetics of polymeric micellar formulation of curcumin10.1002/bmc.795 ↗
16. Solubilization of hydrophobic drugs by methoxy poly(ethylene glycol)-block–polycaprolactone diblock copolymer micelles: theoretical and experimental data and correlations10.1002/jps.21037 ↗
17. Ma Z, Haddadi A, Molavi O, Lavasanifar A, Lai R, Samuel J. Micelles of poly(ethylene oxide)-b-poly(ε-caprolactone) as vehicles for the solubilization, stabilization, and controlled delivery of curcumin. J Biomed Mater Res A, doi:10.1002/jbm.a.31584.10.1002/jbm.a.31584 ↗
18. Chen HC, Lin HY, Lin CC, Lee MH. The encapsulation of curcumin in micelles. In: Proceedings of the IEEE 31st annual northeast bioengineering conference; 2005. p. 275–6.
19. Nanocarriers as an emerging platform for cancer therapy10.1038/nnano.2007.387 ↗
20. Micellar nanocarriers: pharmaceutical perspectives10.1007/s11095-006-9132-0 ↗
21. Polymeric micelles – a new generation of colloidal drugs10.1016/S0939-6411(99)00039-9 ↗
22. Polymeric micelles for delivery of poorly water-soluble compounds10.1615/CritRevTherDrugCarrierSyst.v20.i5.20 ↗
23. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review10.1016/S0168-3659(99)00248-5 ↗
24. Phase I and pharmacokinetic study of genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies10.1158/1078-0432.CCR-03-0655 ↗
25. Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin10.1038/sj.bjc.6602204 ↗
26. Block copolymer micelles for drug delivery: design, characterization and biological significance10.1016/S0169-409X(00)00124-1 ↗
27. Block copolymer micelles: preparation, characterization and application in drug delivery10.1016/j.jconrel.2005.09.034 ↗
28. Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs10.1016/j.addr.2003.12.004 ↗
29. Structure and design of polymeric surfactant-based drug delivery systems10.1016/S0168-3659(01)00299-1 ↗
30. Diacyllipid-polymer micelles as nanocarriers for poorly soluble anticancer drugs10.1021/nl025604a ↗
31. Polymeric nanoparticle composed of fatty acids and poly(ethylene glycol) as a drug carrier10.1016/S0378-5173(02)00582-3 ↗
32. Evaluation of polymeric nanoparticles composed of cholic acid and methoxy poly(ethylene glycol)10.1016/S0378-5173(01)00756-6 ↗
33. Synthesis and the micellar characteristics of poly(ethylene oxide)–deoxycholic acid conjugates10.1021/la9907634 ↗
34. Opsonization, biodistribution and pharmacokinetics of polymeric nanoparticles10.1016/j.ijpharm.2005.10.010 ↗
35. Parameters influencing the stealthiness of colloidal drug delivery systems10.1016/j.biomaterials.2006.03.039 ↗
36. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays10.1016/0022-1759(83)90303-4 ↗